<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Bone and soft tissue sarcomas, tumors of the skin</journal-id><journal-title-group><journal-title xml:lang="en">Bone and soft tissue sarcomas, tumors of the skin</journal-title><trans-title-group xml:lang="ru"><trans-title>Саркомы костей, мягких тканей и опухоли кожи</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2219-4614</issn><issn publication-format="electronic">2782-3687</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">565</article-id><article-id pub-id-type="doi">10.17650/2782-3687-2022-14-2-22-27</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>SOFT TISSUE SARCOMAS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>САРКОМЫ МЯГКИХ ТКАНЕЙ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Lymphangiosarcoma</article-title><trans-title-group xml:lang="ru"><trans-title>Лимфангиосаркома – грозное осложнение лимфостаза: обзор литературы</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3872-7478</contrib-id><name-alternatives><name xml:lang="en"><surname>Ivashkov</surname><given-names>V. Yu.</given-names></name><name xml:lang="ru"><surname>Ивашков</surname><given-names>В. Ю.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>16 Krasnaya Presnya St., Moscow 123242</p></bio><bio xml:lang="ru"><p>Александр Сергеевич Денисенко</p><p>123242, Москва, ул. Красная Пресня, 16</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6791-2237</contrib-id><name-alternatives><name xml:lang="en"><surname>Denisenko</surname><given-names>A. S.</given-names></name><name xml:lang="ru"><surname>Денисенко</surname><given-names>А. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Alexander Sergeevich Denisenko</p><p>Bld. 2 8 Trubetskaya St., Moscow 119991</p></bio><bio xml:lang="ru"><p>119991, Москва, ул. Трубецкая, 8, стр. 2</p></bio><email>allexander.pafem@gmail.com</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3563-6001</contrib-id><name-alternatives><name xml:lang="en"><surname>Ushakov</surname><given-names>A. A.</given-names></name><name xml:lang="ru"><surname>Ушаков</surname><given-names>А. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>6 Novatorov St., Moscow 119421</p></bio><bio xml:lang="ru"><p>119421 Москва, ул. Новаторов, 6</p></bio><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Medsi Group</institution></aff><aff><institution xml:lang="ru">Группа компаний «Медси»</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">ФГАОУ ВО Первый Московский государственный медицинский университет им. И.М. Сеченова Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Medtek LLC</institution></aff><aff><institution xml:lang="ru">ООО «Медтэк»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2022-07-07" publication-format="electronic"><day>07</day><month>07</month><year>2022</year></pub-date><volume>14</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><history><date date-type="received" iso-8601-date="2022-07-07"><day>07</day><month>07</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-07-07"><day>07</day><month>07</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2022, Ivashkov V.Y., Denisenko A.S., Ushakov A.A.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2022, Ивашков В.Ю., Денисенко А.С., Ушаков А.А.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="en">Ivashkov V.Y., Denisenko A.S., Ushakov A.A.</copyright-holder><copyright-holder xml:lang="ru">Ивашков В.Ю., Денисенко А.С., Ушаков А.А.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://sarbon.abvpress.ru/jour/article/view/565">https://sarbon.abvpress.ru/jour/article/view/565</self-uri><abstract xml:lang="en"><p>Lymphangiosarcoma is a rare and aggressive malignancy. It is always associated with chronic lymphedema. This disease was described in 1948 by F.W. Stewart and N. Treves in 6 patients undergoing mastectomy. The incidence of lymphangiosarcoma is varied from 0.07 to 0.45 %. Average time of developing lymphangiosarcoma after mastectomy is 10.3 years. The etiology of this malignant tumor remains uncertain. Histologically LAS arises from epithelial cells of lymphatic vessels in the area of chronic lymphedema. There is no standard treatment of lymphangiosarcoma. Radiation therapy and chemotherapy do not significantly improve the survival rate. At the moment, wide local excision and amputation offer the best chance for long-term survival. Unfortunately, the prognosis remains poor.<bold>The study objective</bold> – is to draw attention to lymphangiosarcoma and to show the importance of its prevention.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Лимфангиосаркома</bold> – редкое и агрессивное злокачественное новообразование. Его развитие напрямую ассоциировано с хроническим лимфостазом. Это заболевание впервые было описано в 1948 г. Ф.В. Стюартом и Н. Тревесом у 6 пациентов, перенесших мастэктомию. Заболеваемость лимфангиосаркомой колеблется в пределах от 0,07 до 0,45 %. Среднее время развития данной патологии после мастэктомии составляет 10,3 года. Этиология этой злокачественной опухоли остается неясной. Гистологически лимфангиосаркома возникает из эпителиальных клеток лимфатических сосудов в области хронического лимфостаза. Общепринятых стандартов лечения данного заболевания нет. Лучевая терапия и химиотерапия существенно не увеличивают показатели выживаемости. На сегодняшний день широкое местное иссечение тканей и ампутация обеспечивают лучшие показатели долгосрочной выживаемости. Однако, к сожалению, прогноз лимфангиосаркомы остается неблагоприятным.<bold>Цель работы</bold> – привлечь внимание к такому заболеванию, как лимфангиосаркома, и показать важность его профилактики.</p></trans-abstract><kwd-group xml:lang="en"><kwd>lymphangiosarcoma</kwd><kwd>angiosarcoma</kwd><kwd>lymphedema</kwd><kwd>mastectomy</kwd><kwd>Stewart–Treves syndrome</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>лимфангиосаркома</kwd><kwd>ангиосаркома</kwd><kwd>лимфостаз</kwd><kwd>мастэктомия</kwd><kwd>синдром Стюарта–Тривса</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Stewart F.W., Treves N. Lymphangiosarcoma in postmastectomy lymphedema; a report of six cases in elephantiasis chirurgica. Cancer 1948;1(1):64–81. DOI: 10.1002/1097-0142(194805)1: 1&lt;64::aid-cncr2820010105&gt;3.0.co;2-w.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Woodward A.H., Ivins J.C., Soule E.H. Lymphangiosarcoma arising in chronic lymphedematous extremities. Cancer 1972;30(2):562–72. DOI: 10.1002/1097-0142(197208)30: 2&lt;562::aid-cncr2820300237&gt;3.0.co;2-v.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>MacKenzie D.H. Lymphangiosarcoma arising in chronic congenital and idiopathic lymphoedema. J Clin Pathol 1971;24(6):524–9. DOI: 10.1136/jcp.24.6.524.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Dyroff S., Layfield L.J., Crim J. Angiosarcoma arising in massive localized lymphedema. Skeletal Radiol 2020;49(5):815–8. DOI: 10.1007/s00256-020-03373-4.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Lowenstein S. Der Aetiologische Zusammengang zwischen akutem und malignem Trauma und Sarkom. Beitrdge zur Klinischen Chirurgie 1906;48:708–24.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Fitzpatrick PJ. Lymphangiosarcoma and breast cancer. Can J Surg 1969;12:172–7.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Shirger A. Postoperative lymphedema: etiologic and diagnostic factors. Med Clin North Am 1962;46:1045–50. DOI: 10.1016/s0025-7125(16)33688-4.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Kaufmann T., Chu F., Kaufman R. Post-mastectomy lymphangiosarcoma (Stewart–Treves syndrome): report of two long-term survivals. Br J Radiol 1991;64:857–60. DOI: 10.1259/0007-1285-64-765-857.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>McHaffie D.R., Kozak K.R., Warner T.F. et al. Stewart–Treves syndrome of the lower extremity. J Clin Oncol 2010;28(21):e351–2. DOI: 10.1200/JCO.2009.26.0406.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Hsu A., Matera R., Dizon S.D. Stewart–Treves syndrome. Lancet Oncol 2020;21(10):e495. DOI: 10.1016/S1470-2045(20)30274-6.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Sordillo P.P., Chapman R., Hajdu S.I. et al. Lymphangiosarcoma. Cancer 1981;48(7):1674–9. DOI: 10.1002/1097-0142(19811001)48: 7&lt;1674::aid-cncr2820480733&gt;3.0.co;2-h.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Stark R., Dwyer E., De Forest M. Effect of surgical ablation of regional lymph nodes on survival of skin homografts. Ann N Y Acad Sci 1960;87:140–8. DOI: 10.1111/j.1749-6632.1960.tb23186.x.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Ruocco V., Schwartz R.A., Ruocco E. Lymphedema: an immunologically vulnerable site for development of neoplasms. J Am Acad Dermatol 2002;47(1):124–7. DOI: 10.1067/mjd.2002.120909.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Schreiber H., Barry F.M., Russell W.C. et al. Stewart–Treves syndrome. A lethal complication of postmastectomy lymphedema and regional immune deficiency. Arch Surg 1979;114(1):82–5. DOI: 10.1001/archsurg.1979.01370250084018.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Futrell J.W., Albright N.L., Myers G.H. Prevention of tumor growth in an ‘immunologically privileged site’ by adoptive transfer of tumor specific transplantation immunity. J Surg 1972;12(2):62–9. DOI: 10.1016/0022-4804(72)90122-9.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Ruocco V., Brunetti G., Puca R.V., Ruocco E. The immunocompromised district: a unifying concept for lymphoedematous, herpes-infected and otherwise damaged sites. J Eur Acad Dermatol Venereol 2009;23(12):1364–73. DOI: 10.1111/j.1468-3083.2009.03345.x.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Alessi E., Sala F., Berti E. Angiosarcomas in lymphedematous limbs. Am J Dermatopathol 1986;8(5):371–8. DOI: 10.1097/00000372-198610000-00002.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Cozen W., Bernstein L., Wang F. et al. The risk of angiosarcoma following primary breast cancer. Br J Cancer 1999;81(3):532–6. DOI: 10.1038/sj.bjc.6690726.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Sharma A., Schwartz R.A. Stewart–Treves syndrome: pathogenesis and management. J Am Acad Dermatol 2012;67(6):1342–8. DOI: 10.1016/j.jaad.2012.04.028.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>McConnell E.M., Haslam P. Angiosarcoma in post-mastectomy lymphoedema; a report of 5 cases and a review of the literature. Br J Surg 1959;46(198):322–32. DOI: 10.1002/bjs.18004619804.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Aygit A.C., Yildirim A.M., Dervisoglu S. Lymphangiosarcoma in chronic lymphoedema. Stewart–Treves syndrome. J Hand Surg Br 1999;24(1):135–7. DOI: 10.1054/jhsb.1998.0049.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Schmitz-Rixen T., Horsch S., Arnold G., Peters P.E. Angiosarcoma in primary lymphedema of the lower extremity Stewart–Treves syndrome. Lymphology 1984;17(2):50–3.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Hultberg B.M. Angiosarcomas in chronically lymphedematous extremities. Two cases of Stewart–Treves syndrome. Am J Dermatopathol 1987;9(5):406–12. DOI: 10.1097/00000372-198710000-00006.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Chopra S., Ors F., Bergin D. MRI of angiosarcoma associated with chronic lymphoedema: Stewart–Treves syndrome Br J Radiol 2007;80(960):e310–3. DOI: 10.1259/bjr/19441948.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Nakazono T., Kudo S., Matsuo Y. et al. Angiosarcoma associated with chronic lymphedema (Stewart–Treves syndrome) of the leg: MR imaging. Skeletal Radiol 2000;29(7):413–6. DOI: 10.1007/s002560000225.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Dawlatly S.L., Dramis A., Sumathi V.P., Grimer R.J. Stewart–Treves syndrome and the use of positron emission tomographic scanning. Ann Vasc Surg 2011;25(5):699.e1–3. DOI: 10.1016/j.avsg.2010.12.027.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Grobmyer S.R., Daly J.M., Glotzbach R.E., Grobmyer A.J. 3rd. Role of surgery in the management of postmastectomy extremity angiosarcoma (Stewart–Treves syndrome). J Surg Oncol 2000;73(3):182–8. DOI: 10.1002/(sici)1096-9098(200003)73: 3&lt;182::aid-jso14&gt;3.0.co;2-n.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>DiSimone R.N., El-Mahdi A.M., Hazra T., Lott S. The response of Stewart–Treves syndrome to radiotherapy. Radiology 1970;97(1):121–5. DOI: 10.1148/97.1.121.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Appelqvist P., Salmo M., Rissanen P., Wiklund T. Response of postmastectomy lymphangiosarcoma to radiotherapy: Report of four cases. Strahlenther Onkol 1990;166(3):194–8.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Breidenbach M., Rein D., Schmidt T. et al. Intra-arterial mitoxantrone and paclitaxel in a patient with Stewart-Treves syndrome: selection of chemotherapy by an ex vivo ATP-based chemosensitivity assay. Anticancer Drugs 2000;11(4):269–73. DOI: 10.1097/00001813-200004000-00007.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Malhaire J., Labat J., Simon H. et al. One case of Stewart–Treves syndrome successfully treated at two years by chemotherapy and radiation therapy in a 73-yearold woman. Acta Oncol 1997;36(4):442–3. DOI: 10.3109/02841869709001296.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Yap B.S., Yap H.Y., McBride C.M., Bodey G.P. Chemotherapy for postmastectomy lymphangiosarcoma. Cancer 1981;47(5):353–856. DOI: 10.1002/1097-0142(19810301)47: 5&lt;853::aid-cncr2820470507&gt;3.0.co;2-0.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Stewart N.J., Pritchard D.J., Nascimento A.G., Kang Y.K. Lymphangiosarcoma following mastectomy. Clin Orthop Rel Res 1995;320:135–41. DOI: 10.1097/00003086-199511000-00023.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Murgia R., Gross G. Stewart–Treves syndrome. Treasure Island (FL): StatPearls Publishing; 2021 Jan. Available at: https://www.ncbi.nlm.nih.gov/books/NBK507833/.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Noguchi M., Hasegawa H., Tajiri K. et al. Stewart–Treves syndrome. A report of two cases with a review of Japanese literature. Jpn J Surg 1987;17(5):407–12. DOI: 10.1007/BF02470642.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Vojtíšek R., Sukovská E., Kylarová M. et al. Stewart–Treves syndrome: case report and literature review. Rep Pract Oncol Radiother 2020;25(6):934–8. DOI: 10.1016/j.rpor.2020.09.006.</mixed-citation></ref><ref id="B37"><label>37.</label><citation-alternatives><mixed-citation xml:lang="en">Ivashkov V.Yu., Sobolevsky V.A. Surgical treatment of lymphatic edema of the upper extremities in patients after complex treatment of breast cancer. The current state of the problem. Annaly plasticheskoj, rekonstruktivnoj i esteticheskoj hirurgii = Annals of Plastic, Reconstructive and Aesthetic Surgery 2015;3:70–6. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Ивашков В.Ю., Соболевский В.А. Хирургическое лечение лимфатического отека верхних конечностей у пациентов после комплексного лечения рака молочной железы. Современное состояние проблемы. Анналы пластической, реконструктивной и эстетической хирургии 2015;3:70–6.</mixed-citation></citation-alternatives></ref><ref id="B38"><label>38.</label><mixed-citation>Farzaliyev F., Hamacher R., Steinau Professor H.U. et al. Secondary angiosarcoma: a fatal complication of chronic lymphedema. J Surg Oncol 2020;121(1): 85–90. DOI: 10.1002/jso.25598.</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Chang E., Skoracki R., Chang D. Lymphovenous anastomosis bypass surgery. Semin Plast Surg 2018;32(1):22–7. DOI: 10.1055/s-0038-1636510.</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Chang D., Suami H., Skoracki R. A prospective analysis of 100 consecutive lymphovenous bypass cases for treatment of extremity lymphedema. Plast Reconstr Surg 2013;132(5):1305–14. DOI: 10.1097/PRS.0b013e3182a4d626.</mixed-citation></ref><ref id="B41"><label>41.</label><citation-alternatives><mixed-citation xml:lang="en">Ivashkov V.Yu. Inguinal lymph node transplantation in the treatment of secondary lymphatic edema of the hand. Double contrast of lymph nodes. Anatomical examination of the inguinal lymph flap. Annaly plasticheskoj, rekonstruktivnoj i esteticheskoj hirurgii = Annals of Plastic, Reconstructive and Aesthetic Surgery 2016;3:57–63. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Ивашков В.Ю. Трансплантация паховых лимфатических узлов в лечении вторичного лимфатического отека руки. Двойное контрастирование лимфоузлов. Анатомическое исследование пахового лимфатического лоскута. Анналы пластической, реконструктивной и эстетической хирургии 2016;3:57–63.</mixed-citation></citation-alternatives></ref><ref id="B42"><label>42.</label><citation-alternatives><mixed-citation xml:lang="en">Ivashkov V.Yu. BRANT (Breast Reconstruction And Node Transplantation) – simultaneous inguinal lymph node transplantation and delayed breast reconstruction by auto-tissues. A modern concept in reconstructive microsurgery of lymphatic system injuries. Voprosy onkologii = Oncology Issues 2017;6:867–75. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Ивашков В.Ю. BRANT (Breast Reconstruction And Node Transplantation) – одномоментная пересадка паховых лимфатических узлов и отсроченная реконструкция молочной железы аутотканями. Современная концепция в реконструктивной микрохирургии повреждений лимфатической системы. Вопросы онкологии 2017;6:867–75.</mixed-citation></citation-alternatives></ref><ref id="B43"><label>43.</label><mixed-citation>Koshima I., Imai H. Angiosarcoma disappeared with lymphaticovenular anastomoses (LVA): amazing results of Stewart–Treves syndrome case report. Ann Short Rep Clin Images 2019;2:1–2.</mixed-citation></ref></ref-list></back></article>
